ChemPartner PharmaTech Co Ltd Market Cap ($647.79 Million)
Market Cap & Net Worth: ChemPartner PharmaTech Co Ltd (300149)
ChemPartner PharmaTech Co Ltd market cap. ChemPartner PharmaTech Co Ltd (SHE:300149) has a market capitalization of $647.79 Million (CN¥4.43 Billion) as of November 1, 2026. Listed on the SHE stock exchange, this China-based company holds position #10567 globally and #2769 in its home market, demonstrating a 11.96% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ChemPartner PharmaTech Co Ltd's stock price CN¥8.89 by its total outstanding shares 497963992 (497.96 Million). Also see 300149 cash flow metrics for how efficiently the company converts equity into cash flow.
ChemPartner PharmaTech Co Ltd Market Cap History (2015–2026)
ChemPartner PharmaTech Co Ltd market cap history from 2015 to 2026. Data shows change from $1.27 Billion to $647.79 Million (-6.71% CAGR). Check ChemPartner PharmaTech Co Ltd stock quote for real-time trading data and today's change.
ChemPartner PharmaTech Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ChemPartner PharmaTech Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore ChemPartner PharmaTech Co Ltd (300149) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.61x
ChemPartner PharmaTech Co Ltd's market cap is 0.61 times its annual revenue
Latest Price to Earnings (P/E) Ratio
51.94x
ChemPartner PharmaTech Co Ltd's market cap is 51.94 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.40 Billion | $258.64 Million | $64.98 Million | 5.40x | 21.49x |
| 2017 | $1.11 Billion | $275.35 Million | $57.81 Million | 4.02x | 19.15x |
| 2018 | $1.06 Billion | $996.92 Million | $161.08 Million | 1.06x | 6.56x |
| 2019 | $962.52 Million | $1.33 Billion | $138.92 Million | 0.72x | 6.93x |
| 2020 | $1.07 Billion | $1.48 Billion | $154.55 Million | 0.72x | 6.92x |
| 2021 | $1.01 Billion | $1.69 Billion | -$402.25 Million | 0.60x | N/A |
| 2022 | $758.55 Million | $1.33 Billion | $378.59 Million | 0.57x | 2.00x |
| 2023 | $557.44 Million | $1.14 Billion | -$916.75 Million | 0.49x | N/A |
| 2024 | $467.81 Million | $970.20 Million | -$226.47 Million | 0.48x | N/A |
| 2025 | $696.62 Million | $1.13 Billion | $13.41 Million | 0.61x | 51.94x |
Competitor Companies of 300149 by Market Capitalization
Companies near ChemPartner PharmaTech Co Ltd in the global market cap rankings as of November 1, 2026. Also see ChemPartner PharmaTech Co Ltd (300149) total assets for a full breakdown of the balance sheet.
Key companies related to ChemPartner PharmaTech Co Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of ChemPartner PharmaTech Co Ltd (2015–2026)
Market capitalization of ChemPartner PharmaTech Co Ltd from 2015 to today. Between 2015 and today, ChemPartner PharmaTech Co Ltd's market cap moved from $1.27 Billion to $ 647.79 Million, with a yearly change of -6.71%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥647.79 Million | -7.01% |
| 2025 | CN¥696.62 Million | +48.91% |
| 2024 | CN¥467.81 Million | -16.08% |
| 2023 | CN¥557.44 Million | -26.51% |
| 2022 | CN¥758.55 Million | -24.62% |
| 2021 | CN¥1.01 Billion | -5.88% |
| 2020 | CN¥1.07 Billion | +11.09% |
| 2019 | CN¥962.52 Million | -8.93% |
| 2018 | CN¥1.06 Billion | -4.51% |
| 2017 | CN¥1.11 Billion | -20.73% |
| 2016 | CN¥1.40 Billion | +10.34% |
| 2015 | CN¥1.27 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of ChemPartner PharmaTech Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $647.79 Million USD |
| MoneyControl | $647.79 Million USD |
| MarketWatch | $647.79 Million USD |
| marketcap.company | $647.79 Million USD |
| Reuters | $647.79 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ChemPartner PharmaTech Co Ltd
ChemPartner PharmaTech Co.,Ltd. engages in the microecological nutrition and healthcare businesses worldwide. The company operates in two segments, Microecological Nutrition and Medical Business; and Pharmaceutical Research and Development Service and Production Outsourcing Business. It offers prebiotic products and the provision of microecological medical services. The company provides comprehen… Read more